RELV (RELV) Stock Price & Analysis
RELV (RELV) rose 0.00% to USD 2.25 as of June 10, 2026 at 07:13 UTC, according to Nexqual real-time market data.
RELV last closed at USD 2.25; the session ranged USD 2.25–2.25 on volume of 200 shares. Market capitalization is $2.57M, with a 52-week range of USD 1.7–3.15 (OID). Source: Nexqual, June 10, 2026 at 07:13 UTC.
Key Statistics (as of June 10, 2026 at 07:13 UTC)
| Price | USD 2.25 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 2.25 |
| Open | USD 2.25 |
| Day Range | USD 2.25 – 2.25 |
| 52-Week Range | USD 1.7 – 3.15 |
| Volume | 200 shares |
| Market Cap | $2.57M |
| Exchange | OID |
Technical Analysis (RELV)
Nexqual's technical model rates RELV "BUY" based on 5 bullish and 1 bearish signals across 123 daily candles, as of June 10, 2026 at 07:13 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 84.6 (overbought) |
| vs SMA50 | Above (USD 2.1) |
| MACD | 0.05 (positive) |
Analyst Ratings (RELV)
Wall Street analysts rate RELV "None", per Nexqual as of June 10, 2026 at 07:13 UTC.
| Consensus Rating | None |
|---|
Earnings (RELV)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2010-06-30 | USD 0.14 vs est 0.21 ▼ miss |
| 2010-03-31 | USD 0.42 vs est 0.42 ▲ beat |
Source: Nexqual, June 10, 2026 at 07:13 UTC.
Financials & Fundamentals (RELV)
| Total Revenue | $35.13M |
|---|---|
| Revenue Growth (YoY) | -5.30% |
| Gross Margin | +72.94% |
| Operating Margin | -1.93% |
| Profit Margin | -0.50% |
| ROE | -1.53% |
| Debt / Equity | 14.28 |
| Current Ratio | 1.67 |
| Total Cash | $3.34M |
| Total Debt | $1.63M |
| Free Cash Flow | $-269,857 |
Source: Nexqual, June 10, 2026 at 07:13 UTC.
Financial Health Score (RELV)
Nexqual rates RELV's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 07:13 UTC.
| Growth | Weak — Revenue -8% YoY (annual), declining |
|---|---|
| Profitability | Solid — Gross margin 73%, operating -2% |
| Balance Sheet | Strong — $3M cash vs $2M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$270K, burning cash |
| Efficiency | Critical — ROE -2%, ROA -0.9% |
Ownership (RELV)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 1.14M |
| Float | 1.10M |
| Short % of Float | +2.19% |
Source: Nexqual, June 10, 2026 at 07:13 UTC.
Leadership (RELV)
RELV is led by Ryan A. Montgomery (age 51), CEO & Director, per Nexqual as of June 10, 2026 at 07:13 UTC.
| CEO & Director | Ryan A. Montgomery (age 51) |
|---|---|
| Co-Founder & Chairman | Robert L. Montgomery (age 83) |
| Senior VP & CFO | Steven D. Albright (age 63) |
| Senior VP & COO | Debra P. Bernardoni (age 54) |
| Chief Scientific Advisor | Alfredo Galvez |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MTEX | Mannatech, Incorporated | USD 5.59 | ▼ 1.93% |
| NATR | Nature's Sunshine Products, Inc | USD 20.14 | ▲ 1.77% |
| PRPH | ProPhase Labs, Inc. | USD 0.1 | ▼ 9.09% |
| NAII | Natural Alternatives Internatio | USD 2.51 | ▲ 0.2% |
| RMCF | Rocky Mountain Chocolate Factor | USD 1.6 | ▼ 4.76% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:13 UTC. This page is informational and not investment advice.